Fattorutto, Maurizio Bouckaert, Yves Brauner, Jonathan Franck, Stéphane Bouton, Fabrice Heuse, Danielle Bouckaert, Charlotte Bruyneel, Arnaud
Published in
Journal of Thrombosis and Thrombolysis
The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hosp...
Korevaar, Daniël A. Aydemir, Ilayda Minnema, Maartje W. Azijli, Kaoutar Beenen, Ludo F. Heijmans, Jarom van Es, Nick al Masoudi, Mohanad Meijboom, Lilian J. Middeldorp, Saskia
...
Published in
Journal of Thrombosis and Thrombolysis
COVID-19 patients have increased risk of pulmonary embolism (PE), but symptoms of both conditions overlap. Because screening algorithms for PE in COVID-19 patients are currently lacking, PE might be underdiagnosed. We evaluated a screening algorithm in which all patients presenting to the ED with suspected or confirmed COVID-19 routinely undergo D-...
Goldin, Mark Lin, Stephanie K. Kohn, Nina Qiu, Michael Cohen, Stuart L. Barish, Matthew A. Gianos, Eugenia Diaz, Anise Richardson, Safiya Giannis, Dimitrios
...
Published in
Journal of Thrombosis and Thrombolysis
There is a need to discriminate which COVID-19 inpatients are at higher risk for venous thromboembolism (VTE) to inform prophylaxis strategies. The IMPROVE-DD VTE risk assessment model (RAM) has previously demonstrated good discrimination in non-COVID populations. We aimed to externally validate the IMPROVE-DD VTE RAM in medical patients hospitaliz...
Corrochano, Mariana Acosta-Isaac, René Mojal, Sergi Miqueleiz, Sara Rodriguez, Diana Quijada-Manuitt, María Ángeles Fraga, Edmundo Castillo-Ocaña, Marta Amaro-Hosey, Kristopher Albiol, Nil
...
Published in
Journal of Thrombosis and Thrombolysis
Anticoagulant therapy is a cornerstone treatment for coronavirus disease 2019 (COVID-19) due to the high rates of thromboembolic complications associated with this disease. We hypothesized that chronic antithrombotic therapy could play a protective role in patients hospitalized for COVID-19. Retrospective, observational study of all patients admitt...
Marchandot, Benjamin Carmona, Adrien Trimaille, Antonin Curtiaud, Anais Morel, Olivier
Published in
Journal of Thrombosis and Thrombolysis
Mennuni, Marco G. Rolla, Roberta Grisafi, Leonardo Spinoni, Enrico G. Rognoni, Andrea Lio, Veronica Castello, Luigi M. Sainaghi, Pier P. Pirisi, Mario Avanzi, Gian Carlo
...
Published in
Journal of Thrombosis and Thrombolysis
Patients with Coronavirus Disease-2019 (COVID‐19) have haemostatic dysfunction and are at higher risk of thrombotic complications. Although age is a major risk factor for outcome impairment in COVID-19, its impact on coagulative patterns here is still unclear. We investigated the association of Endogenous Thrombin Potential (ETP) with thrombotic an...
Gülcü, Oktay Aksakal, Emrah Aydemir, Selim Doğan, Remziye Saraç, İbrahim Aydın, Sidar Şiyar Öztürk, Mustafa Aksu, Uğur Kalkan, Kamuran Tanboğa, İbrahim Halil
...
Published in
Journal of Thrombosis and Thrombolysis
Although COVID-19 disease primarily affects the respiratory system, it has been seen in many studies that it causes thromboembolic (TE) events in many tissues and organs. So that, to prevent TE can reduce mortality and morbidity. In this context, this study aimed to investigate the relationship between the previous use of warfarin or other new dire...
Buenen, A. G. Sinkeldam, Marijn Maas, Martje L. Verdonschot, Martha Wever, Peter C.
Published in
Journal of Thrombosis and Thrombolysis
Coronavirus disease 2019 (COVID-19) is associated with a high incidence of venous and arterial thromboembolic events. The role of anticoagulation (AC) prior to hospital admission and how different types of oral AC influences the outcome of COVID-19 is currently unknown. This observational study compares the outcome in COVID-19 patients with prior u...
Kiris, Tuncay Avci, Eyüp Ekin, Tuba Akgün, Didar Elif Tiryaki, Mücahit Yidirim, Arafat Hazir, Kutluhan Murat, Bektaş Yeni, Mehtap Altindag, Rojhad
...
Published in
Journal of Thrombosis and Thrombolysis
Objective We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey. Methods This was a multi-center and cross-sectional observational stu...
Koubaissi, Salwa A. Daou, Michella Abi Zeid Mohamad, Rayan Husari, Ahmad
Published in
Journal of Thrombosis and Thrombolysis
Background The management of the Coronavirus disease 2019 (COVID-19) infected patients continues to be challenging. Critically ill COVID patients are at increased risk of serious thrombotic events and hence increased mortality. On the other side, COVID-19 patients are also showing major life-threatening bleeds, especially when systemic anticoagulat...
